Antibodies

Items 201-210 of 353

per page
Set Descending Direction
  1. anti-Lipocalin-2 (rat), pAb
    AG-25A-0088
    AG-25A-0088-C100100 µg
    CHF 190.00
    Western blot analysis using anti-Lipocalin-2 (rat), pAb (Prod. No. AG-25A-0088) at 1:4'000 dilution.
1: Rat Lipocalin-2 (FLAG®-tagged).
2: Mouse Lipocalin-2 (FLAG®-tagged).
3: Human Lipocalin-2 (FLAG®-tag
  2. anti-Lipoma Preferred Partner, pAb (IG-817)
    AG-25T-0106
    AG-25T-0106-C05050 µg
    CHF 350.00
    Immunocytochemical staining of a rat cardiac fibroblast using anti-Lipoma Preferred Partner, pAb (IG-817) (Prod. No. AG-25T-0106) (LPP; red fluorescence) and a green-fluorescent phalloidin derivative staining filamentous actin. LPP is a protein related to
  3. anti-Listeria sp. p60, mAb (P6017)
    AG-20A-0023
    AG-20A-0023-C05050 µg
    CHF 290.00
    AG-20A-0023-C100100 µg
    CHF 390.00
    Western Blot analysis using anti-Listeria monocytogenes, mAb (P6017) (Prod. No. AG-20A-0023) at 1:5000 dilution.1: Recombinant L. monocytogenes p60. 2: Culture media of L. monocytogenes.
  4. anti-Listeria sp. p60, pAb
    AG-25A-0019
    AG-25A-0019-C100100 µg
    CHF 390.00
    Western blot analysis using anti-Listeria sp. p60, pAb (Prod. No. AG-25A-0019).
1: Culture media of Listeria monocytogenes.
  5. anti-LPS (Legionella pneumophila), mAb (rec.) (PHK121-H2)
    AG-27B-6325
    AG-27B-6325-C05050 µg
    CHF 330.00
  6. anti-LYVE-1 (human), pAb
    AG-25T-0101
    AG-25T-0101-C05050 µg
    CHF 345.00
    anti-LYVE-1 (human), pAb
  7. anti-LYVE-1 (human), pAb
    AG-25T-0100
    AG-25T-0100-C100100 µg
    CHF 320.00
    anti-LYVE-1 (human), pAb
  8. anti-LYVE-1 (mouse), pAb
    AG-25T-0102
    AG-25T-0102-C100100 µg
    CHF 320.00
    anti-LYVE-1 (mouse), pAb
  9. anti-LYVE-1, pAb
    AG-25T-0103
    AG-25T-0103-C05050 µg
    CHF 345.00
  10. anti-MDA5 (human), mAb (Hely-1)
    AG-20B-0013
    AG-20B-0013-C100100 µg
    CHF 460.00

Items 201-210 of 353

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.